Ignite Creation Date:
2024-05-05 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00427401
Status:
TERMINATED
Last Update Posted:
2008-09-29
First Post:
2007-01-25
Brief Title:
A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-Weeks
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Double Blind Placebo Controlled Parallel Group Study To Evaluate The Safety Tolerability Pharmacokinetics And Pharmacodynamics Of PF-00915275 After Oral Administration To Subjects With Type 2 Diabetes Mellitus For 4-Weeks
Status:
TERMINATED
Status Verified Date:
2008-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
This study was terminated May 7 2007 The study stopped due to tablet formulation issues No safety issues were involved in the termination decision
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety tolerability pharmacokinetics PK and pharmacodynamics PD of PF-00915275 following administration to adult human subjects with T2DM for 4-weeks The primary end point is glucose lowering 24 hour mean glucose concentration
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None